BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22382182)

  • 1. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India.
    Anand MS; Varma N; Varma S; Rana KS; Malhotra P
    Indian J Med Res; 2012; 135(1):42-8. PubMed ID: 22382182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India.
    Sazawal S; Chhikara S; Singh K; Chaubey R; Mahapatra M; Seth T; Saxena R
    Indian J Pathol Microbiol; 2019; 62(2):256-260. PubMed ID: 30971550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients.
    Mir R; Ahmad I; Javid J; Zuberi M; Yadav P; Shazia R; Masroor M; Guru S; Ray PC; Gupta N; Saxena A
    Indian J Cancer; 2015; 52(3):314-8. PubMed ID: 26905124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
    Arana-Trejo RM; Ruíz Sánchez E; Ignacio-Ibarra G; Báez de la Fuente E; Garces O; Gómez Morales E; Castro Granados M; Ovilla Martínez R; Rubio-Borja ME; Solís Anaya L; Herrera P; Delgado Llamas J; Kofman S
    Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
    Haaß W; Kleiner H; Weiß C; Haferlach C; Schlegelberger B; Müller MC; Hehlmann R; Hofmann WK; Fabarius A; Seifarth W; ;
    PLoS One; 2015; 10(6):e0129648. PubMed ID: 26087013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir.
    Azad NA; Shah ZA; Pandith AA; Khan MS; Rasool R; Rasool J; Aziz SA
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1479-1485. PubMed ID: 29936718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients.
    Khazaal MS; Hamdan FB; Al-Mayah QS
    Mol Genet Genomic Med; 2019 Aug; 7(8):e809. PubMed ID: 31206255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR-ABL Gene Transcript Types of Patients with Chronic Myelogenous Leukemia in Yogyakarta, Indonesia.
    Paramita DK; Hutajulu SH; Syifarahmah A; Sholika TA; Fatmawati S; Aning S; Sulistyawati D; Wahyuni S; Taroeno-Hariadi KW; Kurnianda J
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1545-1550. PubMed ID: 32592347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia].
    Rosas-Cabral A; Martínez-Mancilla M; Ayala-Sánchez M; Vela-Ojeda J; Bahena-Reséndiz P; Vadillo-Buenfil M; Aviña-Zubieta JA; Salazar-Exaire D; Miranda-Peralta E; Marroquín A; Longoria-Revilla E
    Gac Med Mex; 2003; 139(6):553-9. PubMed ID: 14723051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts.
    Sharma P; Kumar L; Mohanty S; Kochupillai V
    Ann Hematol; 2010 Mar; 89(3):241-7. PubMed ID: 19714331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
    Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H
    Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and comparison of clinicohematological parameters and molecular and cytogenetic response of two Bcr/Abl fusion transcripts.
    Polampalli S; Choughule A; Negi N; Shinde S; Baisane C; Amre P; Subramanian PG; Gujral S; Prabhash K; Parikh P
    Genet Mol Res; 2008 Oct; 7(4):1138-49. PubMed ID: 19048492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM; Kordofani AA; Fadl-Elmula IM
    Saudi Med J; 2013 Jan; 34(1):29-33. PubMed ID: 23299156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of
    DE Oliveira Sales L; Mesquita FP; DE Sousa Portilho AJ; DE Moraes Filho MO; DE Moraes MEA; Montenegro RC; Moreira-Nunes CA
    In Vivo; 2019; 33(4):1119-1124. PubMed ID: 31280200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia.
    Perego RA; Costantini M; Cornacchini G; Gargantini L; Bianchi C; Pungolino E; Rovida E; Morra E
    Eur J Cancer; 2000 Jul; 36(11):1395-401. PubMed ID: 10899653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection by polymerase chain reaction of BCR/ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation.
    Bianchi C; Cairoli R; Marenco P; Muti G; Del Monte U; Perego RA
    Eur J Cancer; 1995; 31A(2):197-201. PubMed ID: 7718325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Bcr-Abl Gene Rearrangement among Bangladeshi Chronic Myeloid Leukaemia Patients.
    Dipta TF; Datta A; Tarif A; Mottalib MA; Yunus AM; Muttalib MA; Choudhury S; Islam MA
    Mymensingh Med J; 2017 Apr; 26(2):380-387. PubMed ID: 28588176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.